10002454 J Clin Psychiatry / Document Archive

Psychiatrist.com Home    Keyword Search

Close [X]

Search Our Sites

Enter search terms below (keywords, titles, authors, or subjects). Then select a category to search and press the Search button. All words are assumed to be required. To search for an exact phrase, put it in quotes. To exclude a term, precede it with a minus sign (-).

Keyword search:

Choose a category:

Choosing the appropriate category will greatly improve your chances of finding the best match.

All files at our sites: J Clin Psychiatry, Primary Care Companion, CME Institute, and MedFair

Search materials from our journals:

Abstracts from The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements

PDFs of the full text of The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements (Net Society Platinum [paid subscribers])

PDFs of the full text of The Primary Care Companion to The Journal of Clinical Psychiatry, 1999–present

Search CME offerings:

CME Institute, including CME from journals , supplements, and Web activities for instant CME credit (Net Society Gold [registered users]); also includes information about our CME program

CME activities from regular issues of The Journal of Clinical Psychiatry (Net Society Gold [registered users])

CME Supplements from The Journal of Clinical Psychiatry (Net Society Gold [registered users])

 

The article you requested is

Academic Highlights: Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms.[CME]

J Clin Psychiatry 2006;67:310-321
Copyright 2006 Physicians Postgraduate Press, Inc.

To view this item, select one of the options below.

  1. NONSUBSCRIBERS
    1. Purchase this PDF for $30
      If you are not a paid subscriber, you may purchase the PDF.
      (You'll need the free Adobe Acrobat Reader.)
    2. Subscribe
      Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
  2. PAID SUBSCRIBERS
    1. Activate
      If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
    2. Sign in
      As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
  1. Did you forget your password?

Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email

| 54.237.95.6

Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms

his Academic Highlights section of The Journal of Clinical Psychiatry presents the highlights from the teleconference "Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms," which was held July 27, 2005. This report was prepared by the CME Institute of Physicians Postgraduate Press, Inc. and was supported by an educational grant from Eli Lilly and Company.

The planning teleconference was chaired by Madhukar H. Trivedi, M.D., Department of Psychiatry, University of Texas, Southwestern Medical Center at Dallas. The faculty were Wayne J. Katon, M.D., Department of Psychiatry, University of Washington, Seattle; Ella Daly, M.B., M.R.C.Psych., Department of Psychiatry, University of Texas, Southwestern Medical Center at Dallas; Anita H. Clayton, M.D., David C. Wilson Professor and Vice Chair, Medical Director, University of Virginia Center for Psychiatric Clinical Research, Charlottesville; and Ellen Frank, Ph.D., Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pa.

Faculty financial disclosure: In the spirit of full disclosure and in compliance with all ACCME Essential Areas and Policies, the faculty for this CME article were asked to complete a statement regarding all relevant financial relationships between themselves or their spouse/partner and any commercial interest (i.e., a proprietary entity producing health care goods or services) occurring within the 12 months prior to joining this activity. The CME Institute has resolved any conflicts of interest that were identified. The disclosures are as follows: Dr. Trivedi has received grant/research support from National Institute of Mental Health (NIMH), Abbott, Akzo (Organon), Bayer, Bristol-Myers Squibb, Eli Lilly, Forest, GlaxoSmithKline, Janssen, Johnson & Johnson, Mead Johnson, Parke-Davis, Pfizer, Pharmacia & Upjohn, Solvay, Wyeth, and National Alliance for Research on Schizophrenia and Depression (NARSAD) and is a consultant for or member of the speakers bureaus of Bristol-Myers Squibb, Cyberonics, Forest, Janssen, Eli Lilly, Organon, Pfizer, Pharmacia & Upjohn, Solvay, and Wyeth. Dr. Clayton is a consultant for Boehringer-Ingelheim, Eli Lilly, GlaxoSmithKline, Pfizer, Vela, and Wyeth; has received grant/research support from Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, Forest, GlaxoSmithKline, Neuronetics, Pfizer, and Wyeth; has received honoraria from Eli Lilly, GlaxoSmithKline, Pfizer, and Wyeth; and is a member of the speakers/advisory boards of Bayer, Eli Lilly, GlaxoSmithKline, Pfizer, and Wyeth. Dr. Frank is a consultant for Eli Lilly, Pfizer, Pfizer Italia, and Servier and has received grant/research support from Forest, NIMH, and Pittsburgh Foundation. Dr. Katon is a consultant for Eli Lilly and GlaxoSmithKline and has received honoraria from and is a member of the speakers/advisory boards of Eli Lilly, Forest, GlaxoSmithKline, Wyeth, and Pfizer. Dr. Daly has no significant commercial relationships to disclose relative to the presentation.

The opinions expressed herein are those of the authors and do not necessarily reflect the views of the CME provider and publisher or the commercial supporter.